Fielmann Aktiengesellschaft (FLMNF)
USD 46.75
(0.0%)
USD 46.75
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 286.54 Million EUR | 75.48% |
| 2022 | 169.2 Million USD | -33.1% |
| 2021 | 252.93 Million USD | 28.31% |
| 2020 | 197.12 Million USD | -26.29% |
| 2019 | 267.44 Million USD | 6.21% |
| 2018 | 251.81 Million EUR | 0.62% |
| 2017 | 250.26 Million EUR | 2.87% |
| 2016 | 243.27 Million EUR | 0.81% |
| 2015 | 241.32 Million EUR | 5.99% |
| 2014 | 227.68 Million EUR | 13.49% |
| 2013 | 200.62 Million EUR | 9.8% |
| 2012 | 182.7 Million EUR | 4.1% |
| 2011 | 175.52 Million EUR | 4.1% |
| 2010 | 168.61 Million EUR | 3.78% |
| 2009 | 162.48 Million EUR | 0.41% |
| 2008 | 161.82 Million EUR | 18.71% |
| 2007 | 136.31 Million EUR | 27.52% |
| 2006 | 106.89 Million EUR | 25.49% |
| 2005 | 85.18 Million EUR | 354.83% |
| 2004 | 18.72 Million EUR | -32.8% |
| 2003 | 27.86 Million EUR | 3.64% |
| 2002 | 26.88 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 73.41 Million EUR | 153.3% |
| 2024 Q2 | 69.28 Million EUR | 4.63% |
| 2023 FY | 296.93 Million EUR | 75.48% |
| 2023 Q3 | 76.57 Million EUR | 30.56% |
| 2023 Q4 | 84.18 Million EUR | 9.94% |
| 2023 Q1 | 66.83 Million USD | 248.9% |
| 2023 Q2 | 58.64 Million USD | -12.26% |
| 2022 Q4 | 19.15 Million USD | -63.85% |
| 2022 FY | 169.2 Million USD | -33.1% |
| 2022 Q1 | 50.89 Million EUR | 42.38% |
| 2022 Q2 | 40.84 Million EUR | -19.75% |
| 2022 Q3 | 52.98 Million USD | 29.74% |
| 2021 Q2 | 55.12 Million EUR | 29.24% |
| 2021 Q1 | 42.65 Million EUR | -27.3% |
| 2021 Q3 | 86.38 Million EUR | 56.7% |
| 2021 Q4 | 35.74 Million EUR | -58.62% |
| 2021 FY | 252.93 Million USD | 28.31% |
| 2020 Q4 | 58.67 Million EUR | -28.38% |
| 2020 FY | 197.12 Million USD | -26.29% |
| 2020 Q3 | 81.92 Million EUR | 47.24% |
| 2020 Q2 | 55.64 Million EUR | 205.36% |
| 2020 Q1 | 18.22 Million EUR | -89.78% |
| 2019 Q4 | 178.25 Million EUR | 125.39% |
| 2019 FY | 267.44 Million USD | 6.21% |
| 2019 Q2 | 41.92 Million EUR | -51.76% |
| 2019 Q1 | 86.9 Million EUR | 55.74% |
| 2019 Q3 | 79.08 Million EUR | 88.63% |
| 2018 Q2 | 54.76 Million EUR | -10.82% |
| 2018 Q4 | 55.8 Million EUR | -30.2% |
| 2018 FY | 251.81 Million EUR | 0.62% |
| 2018 Q1 | 61.4 Million EUR | 22.38% |
| 2018 Q3 | 79.95 Million EUR | 46.01% |
| 2017 Q3 | 76.3 Million EUR | 21.21% |
| 2017 FY | 250.26 Million EUR | 2.87% |
| 2017 Q1 | 60.83 Million EUR | 7.69% |
| 2017 Q2 | 62.95 Million EUR | 3.48% |
| 2017 Q4 | 50.17 Million EUR | -34.24% |
| 2016 FY | 243.27 Million EUR | 0.81% |
| 2016 Q3 | 70.14 Million EUR | 12.19% |
| 2016 Q2 | 62.51 Million EUR | 15.52% |
| 2016 Q4 | 56.49 Million EUR | -19.46% |
| 2016 Q1 | 54.12 Million EUR | 14.79% |
| 2015 Q3 | 77.13 Million EUR | 44.64% |
| 2015 FY | 241.32 Million EUR | 5.99% |
| 2015 Q4 | 47.14 Million EUR | -38.88% |
| 2015 Q1 | 62.77 Million EUR | 29.15% |
| 2015 Q2 | 53.32 Million EUR | -15.05% |
| 2014 Q4 | 48.6 Million EUR | -31.48% |
| 2014 Q3 | 70.94 Million EUR | 47.38% |
| 2014 Q1 | 59.26 Million EUR | 26.54% |
| 2014 Q2 | 48.13 Million EUR | -18.78% |
| 2014 FY | 227.68 Million EUR | 13.49% |
| 2013 FY | 200.62 Million EUR | 9.8% |
| 2013 Q3 | 60.91 Million EUR | 35.04% |
| 2013 Q2 | 45.1 Million EUR | -4.89% |
| 2013 Q1 | 47.43 Million EUR | 18.86% |
| 2013 Q4 | 46.83 Million EUR | -23.11% |
| 2012 Q3 | 54.48 Million EUR | 30.19% |
| 2012 Q1 | 46.47 Million EUR | 55.27% |
| 2012 Q4 | 39.9 Million EUR | -26.75% |
| 2012 Q2 | 41.84 Million EUR | -9.97% |
| 2012 FY | 182.7 Million EUR | 4.1% |
| 2011 FY | 175.52 Million EUR | 4.1% |
| 2011 Q4 | 29.93 Million EUR | -43.54% |
| 2011 Q3 | 53.02 Million EUR | 26.55% |
| 2011 Q2 | 41.9 Million EUR | -3.87% |
| 2011 Q1 | 43.58 Million EUR | 6.79% |
| 2010 Q2 | 41.33 Million EUR | 12.26% |
| 2010 Q4 | 40.81 Million EUR | -18.52% |
| 2010 Q3 | 50.09 Million EUR | 21.17% |
| 2010 FY | 168.61 Million EUR | 3.78% |
| 2010 Q1 | 36.82 Million EUR | -21.67% |
| 2009 Q2 | 39.2 Million EUR | 18.66% |
| 2009 Q3 | 45.61 Million EUR | 16.36% |
| 2009 Q4 | 47.01 Million EUR | 3.06% |
| 2009 FY | 162.48 Million EUR | 0.41% |
| 2009 Q1 | 33.03 Million EUR | 0.0% |
| 2008 FY | 161.82 Million EUR | 18.71% |
| 2007 FY | 136.31 Million EUR | 27.52% |
| 2006 FY | 106.89 Million EUR | 25.49% |
| 2005 FY | 85.18 Million EUR | 354.83% |
| 2004 FY | 18.72 Million EUR | -32.8% |
| 2003 FY | 27.86 Million EUR | 3.64% |
| 2002 FY | 26.88 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | -24512.788% |
| Ansell Limited | 129.3 Million USD | -121.614% |
| Ansell Limited | 129.3 Million USD | -121.614% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | -820.243% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 18057.437% |
| Psykey, Inc. | -797.5 Thousand USD | 36030.478% |
| ConvaTec Group Plc | 262.7 Million USD | -9.078% |
| ConvaTec Group Plc | 262.7 Million USD | -9.078% |
| Encision Inc. | -640.78 Thousand USD | 44818.259% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 202164.029% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 260763.149% |
| Innovative MedTech Inc. | -4.27 Million USD | 6804.303% |
| LifePoint, Inc. | -7.49 Million USD | 3923.059% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 4522.022% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | -86732.424% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 233273.57% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 61422.596% |
| SmileDirectClub, Inc. | -241.15 Million USD | 218.822% |
| Sector 10, Inc. | -39.84 Thousand USD | 719272.272% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 10.344% |
| SheerVision, Inc. | 155.72 Thousand USD | -183907.166% |
| United Health Products, Inc. | -2.42 Million USD | 11908.877% |
| Vasamed, Inc. | 4.74 Million USD | -5942.361% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 12590.383% |
| Yubo International Biotech Limited | -1.2 Million USD | 23875.434% |